Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of indolecarboxamides. It features a thiazolopyridine core and an indole moiety substituted with chlorine at the fifth position. The molecule has not been approved for any therapeutic use and does not have any known clinical indications or marketed formulations. Its mechanism of action and biological targets are not described in public databases as of June 2025. It is primarily referenced in chemical databases for research purposes and may be used as a chemical probe or intermediate in medicinal chemistry studies[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on N-((1R,2R)-2-(5-chloro-1H-indole-2-carboxamido)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide.